2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details
臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00069186 (ClinicalTrials.gov) | June 2003 | 17/9/2003 | Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis | A Phase III, Multi-Center, Double-Blind, Placebo Controlled, Randomized Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis | Amyotrophic Lateral Sclerosis (ALS) | Drug: Creatine Monohydrate | The Avicena Group | NULL | Active, not recruiting | 21 Years | 80 Years | Both | 107 | Phase 3 | United States |
| 2 | NCT00070993 (ClinicalTrials.gov) | December 2002 | 9/10/2003 | Creatine for the Treatment of Amyotrophic Lateral Sclerosis | Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis | Amyotrophic Lateral Sclerosis | Drug: creatine monohydrate | National Center for Complementary and Integrative Health (NCCIH) | Office of Dietary Supplements (ODS) | Completed | 21 Years | 80 Years | Both | 110 | Phase 2 | United States |